Edgewell Personal Care Company
NYSE:EPCHousehold & Personal Products
+$1.26 today
- Market cap
- $1.30B
- Beta
- 0.49
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.67
- Dividend yield
- 2.52%
Volume 0.50M
Average 0.79M
EPC Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Edgewell Personal Care CompanyNYSE: EPC
Accounts Payables · Q2 FY2026 · quarter ended Mar 2026
Accounts payables outflow grows to $0
Q2 FY2026 accounts payables was $0, compared with $0 a year earlier. Trailing-twelve-month accounts payables was $0. Over 3 fiscal years it compounded at -51.7% a year.
Context
- Accounts payables amounted to 0.1% of revenue in FY2025, down 0.6 pp from a year earlier.
- Accounts payables increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly accounts payables holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 3.3M USD
- Year-over-year change
- -80.6%
- 4-year CAGR
- -39.3%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 3.3M | -80.6% |
| FY2024 | 2024-09-30 | 17M | +156.3% |
| FY2023 | 2023-09-30 | (30.2M) | -203.1% |
| FY2022 | 2022-09-30 | 29.3M | +20.6% |
| FY2021 | 2021-09-30 | 24.3M | — |
Accounts Payables vs competitors
How EPC compares with its peers on the latest reported figures
- EPC's LTM Mar 2026 accounts payables of $0 is the 8th largest of the 9 companies compared; the peer median is $6.5M.
- Accounts payables amounts to 0.0% of revenue for EPC, versus a peer median of 0.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $47.78M | -53.1% | +2.0% | 3.3% | |
| LTM Apr 2026 | $21.4M | +36.3% | +9.4% | 1.7% | |
| LTM Mar 2026 | $20.18M | +520.3% | — | 1.2% | |
| LTM Mar 2026 | $12.5M | +6182.4% | — | 1.1% | |
| LTM Mar 2026 | $5.58M | -151.6% | — | 0.4% | |
| LTM Mar 2026 | $4.92M | -367.3% | — | 0.3% | |
| LTM Mar 2026 | $500K | +111.4% | — | 0.0% | |
| LTM Mar 2026 | $0 | — | -51.7% | 0.0% | |
| LTM Jun 2026 | $0 | — | +117.6% | 0.0% | |
| Peer median (excluding EPC) | $6.5M | +36.3% | +9.4% | 0.7% | |
Competitors are the stored peer set for EPC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 117.8M | 99.5M | 114.7M | 98.6M | 25.4M |
| Depreciation & Amortization | 87.1M | 89.9M | 91.4M | 88M | 88.8M |
| Deferred Income Tax | 9.6M | (13.7M) | (4.5M) | (9.6M) | (21.7M) |
| Stock-Based Compensation | 27.3M | 23.8M | 27.5M | 26.5M | 24.5M |
| Change in Working Capital | (28M) | (82.1M) | 5M | 47.6M | (25.8M) |
| Accounts Receivables | 3.7M | (6.6M) | 31M | (7.3M) | (15.3M) |
| Inventory | (28.8M) | (111.3M) | (32.4M) | 19.7M | 100K |
| Accounts Payables | 24.3M | 29.3M | (30.2M) | 17M | 3.3M |
| Other Working Capital | (27.2M) | 6.5M | 36.6M | 18.2M | (13.9M) |
| Other Non-Cash Items | 15.2M | (15.4M) | (18M) | (20.1M) | 27.2M |
| Operating Cash Flow | 229M | 102M | 216.1M | 231M | 118.4M |
| Capital Expenditures | (56.8M) | (56.4M) | (49.5M) | (56.5M) | (77M) |
| Acquisitions (Net) | 7.2M | (304.4M) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 900K | 5.4M | (1M) | (5.9M) | 4.1M |
| Investing Cash Flow | (48.7M) | (355.4M) | (50.5M) | (62.4M) | (72.9M) |
| Debt Repayment | (21.9M) | 151.1M | (33M) | (83.8M) | 111.5M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (9.2M) | (125.3M) | (75.2M) | (58.5M) | (90.2M) |
| Dividends Paid | (25.6M) | (32.6M) | (31.5M) | (30.7M) | (29.3M) |
| Other Financing Activities | (8.7M) | (10.8M) | (6.8M) | (6.4M) | (22M) |
| Financing Cash Flow | (65.4M) | (17.6M) | (146.5M) | (179.4M) | (30M) |
| Effect of Forex Changes | (400K) | (19.5M) | 8.6M | 3.5M | 1.1M |
| Net Change in Cash | 114.5M | (290.5M) | 27.7M | (7.3M) | 16.6M |
| Free Cash Flow | 172.2M | 45.6M | 166.6M | 174.5M | 41.4M |
Edgewell Personal Care Company
NYSE:EPC
Intrinsic Alpha fair value
Locked
Current Price
$28.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.